VENOUS THROMBOEMBOLISM PROPHYLAXIS AND CLINICAL CONSEQUENCES IN HOSPITALIZED MEDICALLY ILL PATIENTS

被引：0
作者：
Baser, O. [1 ]
Liu, X. [2 ]
Phatak, H. [3 ]
Wang, L. [4 ]
Mardekian, J. [2 ]
Kawabata, H. [3 ]
Petersel, D. [2 ]
Hamilton, M. [3 ]
Ramacciotti, E. [3 ]
机构：
[1] Univ Michigan, STATinMED Res, Ann Arbor, MI 48109 USA
[2] Pfizer Inc, New York, NY USA
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] STATinMED Res, Dallas, TX USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.622
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A115 / A115
页数：1
相关论文
共 50 条
  • [31] Venous Thromboembolism Prophylaxis in Critically Ill Patients
    McLeod, Anne G.
    Geerts, William
    CRITICAL CARE CLINICS, 2011, 27 (04) : 765 - +
  • [32] Venous Thromboembolism Prophylaxis in Critically Ill Patients
    Boonyawat, Kochawan
    Crowther, Mark A.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (01) : 68 - 74
  • [33] Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis
    Al Yami, Majed S.
    Silva, Matthew A.
    Donovan, Jennifer L.
    Kanaan, Abir O.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (01) : 36 - 47
  • [34] Venous Thromboembolism in Acute Medically Ill Patients: Identifying Unmet Needs and Weighing the Value of Prophylaxis
    Dobesh, Paul P.
    Ahuja, Tania
    Davis, George A.
    Fatodu, Hugh
    Francis, William H.
    Hull, Frank P.
    Johnson, Gary L.
    Lenchus, Joshua D.
    Lenoir, Jacqueline Glee
    McPherson, Claudette
    Nemeth, Jeffrey
    Riello, Ralph J., III
    AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (22) : S468 - S474
  • [35] Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis
    Majed S. Al Yami
    Matthew A. Silva
    Jennifer L. Donovan
    Abir O. Kanaan
    Journal of Thrombosis and Thrombolysis, 2018, 45 : 36 - 47
  • [36] Venous thromboembolism prophylaxis in medically ill patients; a mixed treatment comparison meta-analysis
    Kanaan, Abir O.
    Donovan, Jennifer L.
    Al Yami, Majed
    Silva, Matthew A.
    PHARMACOTHERAPY, 2016, 36 (12): : E216 - E216
  • [37] PROPHYLAXIS USE AND 90-DAY COSTS FOR VENOUS THROMBOEMBOLISM, MAJOR AND MINOR BLEEDING EVENT ANALYSIS IN HOSPITALIZED MEDICALLY ILL PATIENTS
    Baser, O.
    Xie, L.
    Yuce, H.
    Du, J.
    Wang, L.
    VALUE IN HEALTH, 2011, 14 (03) : A38 - A38
  • [38] Improvement in quantity and quality of venous thromboembolism prophylaxis for medically ill patients: impact of a clinical pharmacy education program.
    Dobesh, PP
    Stacy, ZA
    PHARMACOTHERAPY, 2004, 24 (10): : 1475 - 1476
  • [39] Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more
    Ageno, Walter
    Lopes, Renato D.
    Yee, Megan K.
    Hernandez, Adrian
    Hull, Russell D.
    Goldhaber, Samuel Z.
    Gibson, C. Michael
    Cohen, Alexander T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (12) : 2089 - 2098
  • [40] Prevention of venous thromboembolism in the medically ill
    Brouse, SD
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (22) : 2338 - +
12345